Skip to main content

Psychological and Psychiatric Consequences of Cannabis

  • Chapter
Handbook of Substance Abuse

Abstract

Cannabis, particularly as smoked as marijuana cigarettes (“joint,” “reefer,” “herb”), is the most frequently abused illicit substance in the United States. Not surprisingly, psychologists and other mental professionals are asked to evaluate large numbers of often youthful people with psychiatric and behavioral problems who also use cannabis. In some individuals, the cannabis use clearly leads to the psychological and psychiatric consequences observed by the clinician. In others, the psychopathology noted antedates the cannabis use or dependence and is a determinate of drug use. Both the drug use and the psychopathology may also occur concurrently and be relatively independent of each other. Further complicating the picture, other illicit drugs and alcohol are often used in association with cannabis. The intermittent or occasional use of cannabis may not be associated with any psychological or psychiatric consequences.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alcoholism and Drug Addiction Research Foundation/World Health Organization. (1981). Report of an ARF/WHO Scientific Meeting on Adverse Health and Behavioral Consequences of Cannabis Use. Toronto, Ontario, Canada: Author.

    Google Scholar 

  • American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders ( 4th ed. ). Washington, DC: Author.

    Google Scholar 

  • Ames, E. (1958). A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model psychoses. Journal of Mental Science, 104, 972–999.

    PubMed  CAS  Google Scholar 

  • Andreasson, S., Allenbeck, P., & Rydberg, U. (1989). Schizophrenia in users and non-users of cannabis: A longitudinal study in Stockholm county. Acta Psychiatrica Scandinavica, 79, 505–510.

    Article  PubMed  CAS  Google Scholar 

  • Beaubrun, M., & Knight, E (1973). Psychiatric assessment of 30 chronic users of cannabis and 30 matched controls. American Journal of Psychiatry, 130, 309–311.

    PubMed  CAS  Google Scholar 

  • Beeder, A. B., & Millman, R. B. (1992). Treatment of patients with psychopathology and substance abuse. In J. H. Lowinson, P. Ruiz, R. B. Millman, & John Langrod (Eds.), Substance abuse: A comprehensive textbook ( 2nd ed., pp. 675–690 ). Baltimore: Williams & Wilkins.

    Google Scholar 

  • Bernhardson, G., & Gunne, L. M. (1972). Forty-six cases of psychosis in cannabis abusers. International Journal of the Addictions, 7, 9–16.

    PubMed  CAS  Google Scholar 

  • Brady, J. V., Foltin, R. W, Fischman. M. W., & Capriotti, R. M. (1986). Behavioral interactions and the effects of marijuana. Alcohol, Drugs, and Driving, 2, 93–103.

    Google Scholar 

  • Breier, A., Buchanan, R. W., Kirkpatrick, B., Davis, O. R., Irish, D., Summerfelt, A., & Carpenter, W. T. (1994). Effects of Clozapine on positive and negative symptoms in outpatients with schizophrenia. American Journal of Psychiatry, 151, 20–26.

    PubMed  CAS  Google Scholar 

  • Brill, H., & Nahas, G. G. (1984). Cannabis intoxication and mental illness. In G. G. Nahas (Ed.), Marijuana in science and medicine (pp. 263–305 ). New York: Raven.

    Google Scholar 

  • Carter, W. E. (1980). Cannabis in Costa Rica: A study of chronic marijuana use. Philadelphia: Institute for the Study of Human Issues.

    Google Scholar 

  • Chaudry, H. R., Moss, H. B., Bashir, A., & Suliman, T. (1991). Cannabis psychosis following bhang ingestion. British Journal of Addiction, 86, 1075–1081.

    Article  PubMed  CAS  Google Scholar 

  • Chopra, G., & Smith, J. (1974). Psychotic reactions following cannabis use in East Indians. Archives of General Psychiatry, 30, 24–27.

    Article  PubMed  CAS  Google Scholar 

  • Clayton, R. R., & Voss, H. L. (1981). Young men and drugs in Manhattan: A casual analysis (NIDA Research Monograph No. 39 ). Washington, DC: U.S. Government Printing Office.

    Google Scholar 

  • Edwards, G. (1983). Psychopathology of a drug experience. British Journal of Psychiatry, 143, 509–512.

    Article  PubMed  CAS  Google Scholar 

  • Ellis, G. M., Mann, M. A., Judson, B. A., Schramm, N. T., & Taschian, A. (1985). Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clinical Pharmacology Therapeutics, 38, 572–578.

    Article  CAS  Google Scholar 

  • Estroff, T. W. & Gold, M. S. (1986). Psychiatric presentations of marijuana abuse. Psychiatric Annals, 16, 221–224.

    Google Scholar 

  • Ghodse, H. (1986). Cannabis psychosis. British Journal of Addiction, 81, 473–478.

    Article  PubMed  CAS  Google Scholar 

  • Grinspoon, L., & Bakalar, J. B. (1986). Psychedelics and arylcyclohexylamines. In A. J. Frances & R. E. Hales (Eds.), Psychiatry update: American Psychiatric Association annual review (Vol. 5, pp. 212–225 ). Washington, DC: American Psychiatric Press.

    Google Scholar 

  • Hall, W., Solowij, N., & Lemon, J. (1994). The health and psychological effects of cannabis (National Drug Strategy Monograph No. 25 ). Canberra, Australia: Australian Government Publishing Service.

    Google Scholar 

  • Hammer, T. (1990). Per Vaglum: Initiation, continuation, or discontinuation of cannabis use in the general population. British Journal ofAddiction, 85, 899–909.

    Article  CAS  Google Scholar 

  • Harding, T., & Knight, F. (1973). Marijuana-modified mania. Archives of General Psychiatry, 29, 635–637.

    Article  PubMed  CAS  Google Scholar 

  • Hunt, C. A., & Jones, R. T. (1980). Tolerance and disposition of tetrahydrocannabinol in man. Journal of Pharmacology and Experimental Therapeutics, 215, 35–44.

    PubMed  CAS  Google Scholar 

  • Jessor, R. (1975). Predicting time of marijuana use: A developmental study of high school youths. In D. J. Lettieri (Ed.), Predicting adolescent drug abuse: A review of issues, methods, and correlates: Research issues, 11. Rockville, MD: National Institute on Drug Abuse.

    Google Scholar 

  • Jessor, R.. & Jessor, S. L. (1977). Problem behavior and psychosocial development: A longitudinal stuck of youth. New York: Academic Press.

    Google Scholar 

  • Jessor, R., Chase, J. A., & Donovan, J. E. (1980). Psychosocial correlates of marijuana use and problem drinking in a national sample of adolescents. American Journal of Public Health, 70, 604–613.

    Article  PubMed  CAS  Google Scholar 

  • Jessor, R., Donovan, J., & Costa, E (1986). Psychoactive correlates of marijuana in adolescent and young adulthood: The past as prologue, in marijuana, cocaine, and traffic society. In H. Moskowitz (Ed.), Alcohol, drugs and driving (Vol. 2, pp. 31–49 ). Santa Monica, CA.

    Google Scholar 

  • Johansson, E., Agurell, S., Hollister, L. E., & Halldin, M. M. (1988). Prolonged apparent half-life of delta-l-tetrahydrocannabinol in plasma of chronic marijuana users. Journal of Pharmacy and Pharmacology, 40, 374–375.

    Article  PubMed  CAS  Google Scholar 

  • Johnson, B. A. (1990). Psychopharmacological effects of cannabis. British Journal of Hospital Medicine, 43, 114–122.

    PubMed  CAS  Google Scholar 

  • Jones, R. T., & Benowitz, N. (1976). The 30-day trip-Clinical studies of cannabis tolerance and dependence. In M. C. Braude & S. Szara (Eds.), The pharmacology of marijuana (pp. 627–642 ). New York: Raven.

    Google Scholar 

  • Jones, R. T., Benowitz, N., & Bachman, J. (1976). Clinical studies of cannabis tolerance and dependence. Annals of the New York Academy of Sciences, 282, 221–239.

    Article  PubMed  CAS  Google Scholar 

  • Jones, R. T., Benowitz, N. L., & Fleming, R. I. (1981). Clinical relevance of cannabis tolerance and dependence. Journal of Clinical Pharmacology, 21 (Suppl.), 143S - I52S.

    Article  PubMed  CAS  Google Scholar 

  • Kandel, D. B. (Ed). (1978). Longitudinal research on drug use: Empirical. findings and methodological issues. Washington, DC: Hemisphere.

    Google Scholar 

  • Kandel, D. B., & Davies, M. (1992). Progression to regular marijuana involvement: Phenomenology and risk factors for near-daily use. In M. Glantz & R. Pickens (Eds.), Vulnerability to drug abuse (pp. 211–254 ). Washington, DC: American Psychological Association.

    Chapter  Google Scholar 

  • Kandel, D. B., Kessler, R., & Margulies, R. (1978). Antecedents of adolescent initiation into stages of drug use: A developmental analysis. In D. B. Kandel (Ed.), Longitudinal research on drug use: Empirical findings and methodological issues (pp. 73–99 ). Washington, DC: Hemisphere.

    Google Scholar 

  • Keup, W. (1970). Psychotic symptoms due to cannabis abuse. Diseases of the Nervous System, 31, 119–126.

    PubMed  CAS  Google Scholar 

  • Khantzian, E. J., & McKenna, G. J. (1979). Acute toxic and withdrawal reactions associated with drug use and abuse. Annals of Internal Medicine, 90, 361–373.

    PubMed  CAS  Google Scholar 

  • Kiplinger, G. G., & Manno, J. E. (1971). Dose response relationships to cannabis in human subjects. Pharmacological Review, 23, 339–347.

    CAS  Google Scholar 

  • Knight, F. (1976). Role of cannabis in psychiatric disturbance. Annals of the New York Academy of Sciences, 282, 64–71.

    Article  PubMed  CAS  Google Scholar 

  • Knudsen, P., & Vilmar, T. (1984). Cannabis and neuroleptic agents in schizophrenia. Acta Psychiatrica Scandinavica, 69, 162–174.

    Article  PubMed  CAS  Google Scholar 

  • Kouri, E., Pope, H. G., Yurgelun-Todd, D., & Gruber, S. (1995). Attributes of heavy vs. occasional marijuana smokers in a college population. Biological Psychiatry. 38, 475–481.

    Article  PubMed  CAS  Google Scholar 

  • Lex, B. W., Griffin, M. L., Mello, N. K., & Mendelson, J. (1989). Alcohol, marijuana and mood states in young women. International Journal of the Addictions, 24, 405–424.

    PubMed  CAS  Google Scholar 

  • Marder, S. R., & Meibach, R. C. (1994). Risperidone in the treatment of schizophrenia. American Journal of Psychiatry, 151, 825–835.

    PubMed  CAS  Google Scholar 

  • Marlotte, D. B. (1972). Marijuana and mutism. American Journal of Psychiatry, 129, 475–477.

    Google Scholar 

  • Mathers, D. C., Ghodse, A. H., Cann, A. W., & Scott, S. A. (1991). Cannabis use in a large sample of acute psychiatric admissions. British Journal of Addiction, 86, 779–784.

    Article  PubMed  CAS  Google Scholar 

  • McLellan, A. T., Woody, G. E., & O’Brien, C. P. (1979). Development of psychiatric illness in drug abusers: Possible role of drug preference. New England Journal of Medicine, 301, 1310–1314.

    Article  CAS  Google Scholar 

  • Mendelson, J. H., Mello, N. K., Lex, B. W., & Bavli, S. (1984). Marijuana withdrawal syndrome in a woman. American Journal of Psychiatry, 141, 1289–1290.

    PubMed  CAS  Google Scholar 

  • Mendhiratta, S. S., Varma, V. K., Dang, R., Malhotra, A. K., Das, K., & Nehra, R. (1988). Cannabis and cognitive functions: A re-evaluation study. British Journal ofAddictions, 20, 57–65.

    Google Scholar 

  • Millman, R. B., & Beeder. A. B. (1994). Treatment of patients for specific drugs of abuse: Cannabis. In M. Galanter & H. D. Kleber (Eds.), The American Psychiatric Press textbook of substance abuse treatment (pp. 91–109 ). Washington, DC: American Psychiatric Press.

    Google Scholar 

  • Millman, R. B., & Sbriglio, R. (1986). Patterns of use and psychopathology in chronic marijuana users. Psychiatric Clinics of North America, 9, 533–545.

    PubMed  CAS  Google Scholar 

  • Musty, R. E., & Kaback, L. (1995). Relationships between motivation and depression in chronic marijuana users. Life Sciences, 56, 2151–2158.

    Article  PubMed  CAS  Google Scholar 

  • National Institute on Drug Abuse. (1995). The monitoring the future study, Institute for Social Research. Ann Arbor: University of Michigan Press.

    Google Scholar 

  • Negrete, J. C. (1988). What’s happened to the cannabis de- bate? British Journal of Addiction, 83, 359–372.

    Article  PubMed  CAS  Google Scholar 

  • Nicholi, A. A. (1983). The non-therapeutic use of psychoactive drugs: A modern epidemic. New England Journal of Medicine, 308, 925–933.

    Article  PubMed  Google Scholar 

  • O’Connell, D. E (1990). Managing the dually diagnosed patient. In D. F. O’Connell (Ed.), Current issues and clinical approaches. New York: Haworth.

    Google Scholar 

  • O’Donnell, J. A., & Clayton, R. R. (1979). The stepping stone hypothesis: A reappraisal. In G. M. Beschner & A. S. Friedman (Eds.), Youth drug abuse: Problems, issues and treatment. Lexington, MA: Lexington Books.

    Google Scholar 

  • O’Donnell, J. A., Voss, H. L., Clayton, R. R., Slatin, G. T., & Room, R. G. (1976). Young men and drugs: A nationwide survey (NIDA Research Monograph No. 5; DHEW Publication No. ADM-76–311). Washington, DC: U.S. Government Printing Office.

    Google Scholar 

  • O’Malley, P. M., Johnston, L. D., & Bachman, J. G. (1985). Cocaine use among American adolescents and young adults. In N. J. Kozel & E. H. Adams (Eds.), Cocaine use in America: Epidemiologic and clinical perspectives (NIDA Research Monograph No. 61, pp. 50–75 ). Washington, DC: National Institute on Drug Abuse.

    Google Scholar 

  • Palsson, A., Thulin, S. O., & Tunving, K. (1982). Cannabis psychosis in South Sweden. Acta Psychiatrica Scandinavica, 66, 311–321.

    Article  PubMed  CAS  Google Scholar 

  • Pope, H. G., & Yurgelun-Todd, D. (1996). The residual cognitive effects of heavy marijuana use in college students. Journal of the American Medical Association, 7, 521–527.

    Article  Google Scholar 

  • Pope, H. G., Gruber, A. J., & Yurgelun-Todd, D. (1995). The residual neuropsychological effects of cannabis: The current status of research. Drug and Alcohol Dependence, 38, 25–34.

    Article  PubMed  Google Scholar 

  • Rohr, J. M., Showlund, S. W, & Martin, T. E. (1989). Withdrawal sequelae to cannabis use. International Journal of the Addictions, 14, 627–631.

    Google Scholar 

  • Rubin V, & Comitas, L. (1975). Psychological assessment. In V. Rubin & L. Comitas (Eds.), Ganja in Jamaica: A medical-anthropological study of chronic marijuana use (pp. 111–119 ). The Hague, Netherlands: Mouton.

    Google Scholar 

  • Rubin, V., & Comitas, L. (1976). Ganja in Jamaica: The effects of marijuana. New York: Anchor/Doubleday.

    Google Scholar 

  • Schwartz, R. H., Gruenwald, E J., Klitzner, M., & Fedio, P. (1989). Short-term memory impairment in cannabis-dependent adolescents. American Journal of Diseases of Children, 143, 1214–1219.

    PubMed  CAS  Google Scholar 

  • Seth, R., & Sinha, S. (1991). Chemistry and pharmacology of cannabis. Progress in Drug Research, 36, 71–115.

    PubMed  CAS  Google Scholar 

  • Smith, D. E. (1968). Acute and chronic toxicity of mari- juana. Journal of Psychedelic Drugs, 2, 37–47.

    Article  Google Scholar 

  • Solomons, K., & Neppe, V. M. (1989). Cannabis-Its clinical effects. South African Medical Journal, 76, 102–104.

    PubMed  CAS  Google Scholar 

  • Stefanis, C., Boulougouris. I., & Liakos, A. (1976). Clinical and psychophysiological effects of cannabis in long-term users. In M. C. Brause & S. Szara (Eds.), Pharmacology of marijuana. New York: Raven.

    Google Scholar 

  • Substance Abuse and Mental Health Services Administration. (1995). Preliminary estimates fions the 1994 National Household Survey on Drug Abuse, Advance Report No. 10. Washington, DC: U.S. Government Printing Office.

    Google Scholar 

  • Thomicroft, G. (1990). Cannabis and psychosis-Is there epidemiological evidence for an association? British Journal of Psychiatry, 157, 25–33.

    Article  Google Scholar 

  • Tien, A. Y., & Anthony, J. C. (1990). Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. Journal of Nervous and Mental Disease, 178, 473–480.

    PubMed  CAS  Google Scholar 

  • Tunving, K. (1985). Psychiatric effects of cannabis use. Acta Psychiatrica Scandinavica, 72, 209–217.

    Article  PubMed  CAS  Google Scholar 

  • Wall, M. E., & Perez-Reyes, M. (1981). The metabolism of delta-9-tetrahydrocannabinol and related cannabinoids in man. Journal of Clinical Pharmacology, 21, 1785–1795.

    Google Scholar 

  • Zablocki, B., Aidala, A., Hansell, S., & White, H. R. (1991). Marijuana use, introspectiveness, and mental health. Journal of Health and Social Behavior, 32, 65–79.

    Article  PubMed  CAS  Google Scholar 

  • Zinberg, N. (1984). Drug, set and setting. New Haven, CT: Yale University Press.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Phariss, B., Millman, R.B., Beeder, A.B. (1998). Psychological and Psychiatric Consequences of Cannabis. In: Tarter, R.E., Ammerman, R.T., Ott, P.J. (eds) Handbook of Substance Abuse. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-2913-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-2913-9_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-3297-6

  • Online ISBN: 978-1-4757-2913-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics